The Inspire Sleep Apnea Implant is a medical device that is implanted in to the body for the treating snoring and obstructive anti snoring (OSA) syndrome.
Obstructive ANTI SNORING Syndrome
Obstructive anti snoring syndrome is a disease caused by relapsing episodes of sleep apnea. This can be a condition where breathing stops for more than 10 seconds, where oxygen saturation in the blood is reduced by a lot more than 4%.
OSA syndrome occurs while asleep, when the muscles of upper airways relax, causing the obstruction of the respiratory system. This leads to deterioration of blood oxygenation and provokes short unconscious wake-up episodes throughout the night. An unhealthy pattern of sleep places pressure on the body, causing increased blood pressure and development of severe diseases. The diseases caused by OSA can be physical, such as for example hypertension, myocardium infarction and stroke. They could also be mental, including depression, chronic fatigue syndrome, loss of memory and concentration.
Before any treatment, a sleep study or perhaps a polysomnography is needed. The polysomnography calculates the apnea index, that is the frequency of apnea episodes during one hour of sleep and determines the severe nature of the condition. The apnea index is considered significant if there are a lot more than 20 apnea episodes each hour, whatever the presence or lack of clinical symptoms.
The gold standard of treatment for OSA syndrome is CPAP-therapy. However, CPAP therapy isn’t for everyone as many people find it uncomfortable to sleep with the mask on the face and the machine itself can be loud, especially since it commonly sits close to the head. Only 25% of patients may use CPAP-therapy for a long period of time.
Therefore, recently Inspire Medical Systems Inc. has think of a very effective solution with the Inspire Sleep Apnea Implant.
How The Inspire Sleep Apnea Implant Works
The Inspire ANTI SNORING Implant is really a battery operated device that promotes electrostimulation of the sublingual nerve. The battery life is approximately 10 years.
The main unit of this device is placed beneath the skin, on the front right side of the chest also it monitors the phase of breathing. The other electrode is implanted for stimulation of the sublingual nerve, which creates muscle tension. This opens top of the airways and allows the tongue to stand out, and helps maintain the airways open during sleep.
As well as the two electrodes, this device also contains a handy small remote switch, which actually turns on the device before sleep and switches it off once awake. This disables the electrodes from disturbing the processes of communication and eating during the active phase of the day, whenever a person needs physiological narrowing of the larynx and tongue movements for these procedures.
The patient may feel light involuntary contractions of the larynx, or tongue movements during initial usage of the device. These movements usually do not cause pain, instead only a minor discomfort. These unpleasant effects disappear after the first few uses of the device.
Generally, the implant ought to be checked 1 or 2 2 times each year. However, depending on situation, an Inspire therapy-trained doctor may consult patients more or less often.
The Inspire Sleep Apnea Implant is only suitable for:
Patients who are more than 22 years old.
Patients who have been diagnosed with moderate or severe obstructive anti snoring syndrome.
Patients with an apnea index in the range of 20 to 65.
Patients who are uncomfortable with using CPAP therapy or didn’t have the desired effect.
Patients with a body mass index of significantly less than 32.
Body mass index (BMI) = weight (kg) / height^2 (m2).
An individual with a weight of 80 kg and a height of 170 cm has
BMI = 80kg / (1.7m ^ 2) = 80 / 2.89 = 27.68 kg/ m2
The Inspire ANTI SNORING Implant could potentially replace CPAP therapy as ‘the gold standard’ of treatment for obstructive sleep apnea syndrome. A report by Dr. Ryan J. et al. has shown that after implantation of the Inspire ANTI SNORING Implant, snoring is greatly decreased. A percentage of “no” or “soft” snoring changed from 22% at start of the treatment to 88% at 12 months and 91% at two years following the treatment. ufabet Also, the apnea index was reduced from 31 to 14. 82% of the patients in the study reported a nightly usage of this therapy for five years. Therefore, it really is evident that this method is impressive and simple to use!
